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Abstract: Objectives: Prostate cancer (PCa) and Benign Prostatic Hyperplasia (BPH) are the leading cause of urinary 
tract disorders in males both of which are characterized by rapid proliferation of cells. This study characterizes both Ki-67 
and E-Cadherin profiles in BPH and PCa biopsies to determine and compare the extent of aggressiveness of cell 
proliferation in BPH and PCa. 
Method: Biopsies were collected from patients clinically diagnosed to be suffering from PCa or BPH and were 
immunohistochemically labelled using Anti-Ki-67 and Anti-ECAD monoclonal antibodies. The sections were treated with 
urea followed by incubation in a microwave to activate the antigens. Primary antibody treatment was done in biotinylated 
goat serum, blocking was done with bovine serum albumin (BSA) and finally secondary antibody staining using Anti-Ki-
67 and Anti-ECAD monoclonal antibodies. 
Results: The expression level of Ki-67 corresponded to the rate of proliferation and size of the tumor cell mass in both 
PCa and BPH. ECAD expression was highly positive in BPH and less positive in PCa- showing onset of malignancy in 
PCa. Certain cell clumps (metastases) stained highly positive to Ki-67 and were located at random intervals within the 
tissue of PCa biopsies, this type of distribution also coincided with ECAD immunonegativity. 
Conclusion: Ki-67 expression indicates the rate of cell proliferation and the aggressiveness of such tumors, while ECAD 
shows defective cytoskeleton and extent of malignancy. Correlating ECAD and Ki-67 gives a direct relationship between 
the rate of cell division, tumor invasion and epithelia structure. This also covers both glandular and fibromuscular 
epithelium 
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INTRODUCTION 
 Recent advances in immunopathogenesis of cancer have 
allowed comparative assessment of molecular biomarkers 
that are prognostic to identifying triad of pathological 
processes and developing prostatic disease conditions such 
as benign prostatic hyperplasia (BPH) and prostate cancer 
(PCa) which presents similar clinical picture and pathogenic 
mechanisms- the triad comprises of assessment of PSA level, 
Digital rectal examination and Trans rectal ultrasound scan 
[1]. Epidemiological profile of prostate dysfunction shows 
that prostate cancer is the second leading cause of cancer 
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related death in men and accounts for 15% and 4% cancer 
cases in developed and developing countries, respectively 
[2]. Whereas, more than two-thirds of men older than fifty 
years have histological evidence of BPH whose proportion 
increases to 80% after age 70 [3].  
 Despite high prevalence of prostate cancer and BPH, 
optimal treatment remains a challenge for health providers 
worldwide. Management of these diseases have been widely 
reported to hinge on standard clinical factors including 
Gleason scoring system, PSA level and measures of tumor 
extent on biopsy and imaging [4]; these were considered 
inadequate. Hence, better and specific prognostic markers 
are required to determine the exact nature and origin of such 
a cancer – this will aid the determination of the molecular 
basis of such cancers and can be used in the prediction of its  
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progression which is normally inaccurate using the existing 
clinical diagnostic methods. It is widely reported that the 
molecular basis of tumor aggressiveness is related to  
1. Uncontrolled tumor proliferation activity – which can 
be assessed by PCNA and Ki-67 antigen;  
2. Adhesion, migration and tumor cell invasiveness – 
especially related to E-cadherin adhesion molecule;  
3. Tumor angiogenesis – which can be immuno-
chemically evaluated by CD34 expression [5, 6]. 
 E-cadherin is a cell surface glycoprotein involved in 
calcium-dependent homotypic cell-to-cell adhesion. It is 
responsible for organization, maintenance and 
morphogenesis of epithelial tissues [7]. It is expressed in 
normal arachnoid tissue, epithelial tissue and in human 
meningioma cells. The cytoplasmic tail of the E-cadherin 
molecules bind to -catenin to form the cadherin – actin 
filament complex, which is necessary for functional cell to 
cell adhesion [8,9]. Suppression of expression or cleavage of 
this adhesion molecule may result in cells acquiring a 
mesenchymal morphology and increased motility [10]. 
During cancer progression to an invasive state, intercellular 
adhesions between tumor cells are disrupted. Thus, 
aggressive tumor cells were hypothesized to have loss of E-
cadherin. Also, decreased E-cadherin expression has 
repeatedly been shown to correlate with a loss of tumor 
differentiation and poor prognosis [6]. This is important in 
differentiating PCa from BPH, although both are 
characterized by rapid cell proliferation, epithelia integrity 
might be retained in BPH while cancerous cells in PCa 
would normally detach from the epithelium as seen in low 
ECAD expression for this category. The extent of such 
ECAD decrease in PCa will also determine the relative rate 
of tumor cell detachment from the epithelium and otherwise 
the degree of aggressiveness of such tumors. 
 Ki-67, a DNA binding protein, is a standard proliferation 
marker for predicting tumor development. It is expressed 
only in dividing cells, either normal or tumor, but absent in 
resting cells. Only cells that over express p53 or p21 may be 
assessed using Ki-67. Thus, the level of Ki-67 expression 
may be used to determine the cell proliferation status [11]. 
Typically, actively growing prostate cancer cells are few and 
the rapidity of growth is at a reduced rate. Hence, the greater 
the proportion of prostate tumor cells with Ki-67 indicates 
the aggressive nature of the cancer. A study by Alan Pollack 
in 2003 [12], shows that when tumor cells stained for Ki-67 
is greater than 7.1%, it is an indication of significant increase 
risk of distant metastasis and death due to prostate cancer. 
 Although, recent studies have evaluated index of 
proliferation, apoptosis, hormone receptors and TGF- 
signaling using both animal and in-vitro models. Despite 
this, Ki-67, the most studied of any immunochemical 
biomarker in prostate cancer, remains an important 
prognostic factor in multivariate analysis. Combination with 
other predictive biomarkers, such as E-cadherin, may be 
beneficial for proper diagnosis and optimization of disease 
management and offset limitations of early immunochemical 
factors. This is believed to further help identify correlation 
between biomarkers and prognostic factors in cancer. This 
study, however, evacuates the distribution of Ki-67 and 
ECAD in the epithelium and glandular tissue of clinically 
diagnosed BPH and PCa biopsies as a function of cell 
proliferation and metastasis to foster comparison and 
transition between PCa and BPH. 
MATERIALS AND METHODS 
Tissue Processing 
 BPH and PCa samples (biopsies) were obtained from 
patients clinically diagnosed and histologically confirmed to 
have the condition(s). The biopsies were fixed in 
formolcalcium (4BPH and 4Pca) and processed 
histologically to obtain paraffin wax embedded sections at 
the pathology lab of University Teaching Hospital, Ado-
Ekiti. 
Histology 
 Tissue sections were processed for routine Hematoxylin 
and Eosin following the methods of Zhang et al. (2012) [13] 
to demonstrate the general morphology of the prostate tissue. 
IMMUNOHISTOCHEMISTRY  
 Cell Proliferation Marker (Ki-67) and E-Cadherin 
(ECAD): the objective is to determine the expression of Ki-
67 and ECAD in BPH and PCa prostate tissues and to 
evaluate the effects of these variations in the expression of 
these two proteins in the progression of BPH and PCA. Ki-
67 is also used in this study to determine progression of 
DNA damage in both conditions. The tissue biopsies were 
initially fixed in formolsaline and embedded in paraffin wax 
in preparation for antigen retrieval. The monoclonal 
antibodies [anti-Ki-67 and anti ECAD were procured from 
Standard Bio Techniques, China]. The reagents were 
purified according the quality assurance specifications and 
antibody was diluted to 1:500 in Phosphate buffer saline 
(PBS).  
 Procedure: the paraffin wax embedded sections were 
mounted on a glass slide in preparation for antigen retrieval 
where the slides were immersed in urea overnight and then 
placed in a microwave for 45 minutes to re-activate the 
antigens and proteins in the tissue sections. Primary antibody 
treatment involved treating the sections with biotinylated 
goat serum for one hour following which the sections were 
transferred to 1% bovine serum albumin (BSA) to block 
non-specific protein reactions. Secondary treatment involved 
the use of diluted anti-Ki-67 and anti-ECAD on the pre-
treated sections for one hour. The immunopositive reactions 
were developed using a polymer 3’3’ Diaminobenzidine 
Tetrachloride (DAB) with colour intensification involving 
the use of mathenamine silver kit. The sections were 
counterstained in Hematoxylin and treated in 1% acid 
alcohol (freshly prepared). 
TRANSFORMATION 
 Mathenamine silver intensification was used on the 
immunoperoxidase preparation after the 
peroxidase/H202/DAB reaction has been carried out to give a 
brown deposit. The sections were then counterstained in 
Hematoxylin. The counterstained sections were washed in 
running tap water, thoroughly rinsed in distilled water, and 
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placed in preheated methenamine silver solution at 60°C for 
five minutes. Although it could be occasionally longer if the 
intensification had been carried out at room temperature. In 
this study, to further increase the clarity, Hematoxylin was 
removed from counterstained nuclei with 1% acid alcohol 
before the silver intensification was carried out. The 
composition of the stock solution was 0.125% silver nitrate 
in 1.5% hexamine. The solution was stored at 4°C. Prior to 
use, 2ml of 5% tetraborate was added to 50ml of the stock 
silver solution giving a pH of 8.0, which was then filtered 
into a coupling jar and protected from sunlight.  
RESULTS AND DISCUSSION 
 The expression of ECAD describes the progression of 
tumors to malignant cancers while that of Ki-67 indicates the 
extent of aggressiveness of such cancers. The detached 
tumor cells shows ECAD immunonegativity compared with 
the surrounding tumor cells that showed ECAD 
immunopositivity (Fig. 2, PCa/S09). The extent of ECAD 
immunonegativity coincided with the extent of the cancer 
tissue invasion such that the lower the ECAD expression 
level, the more invasive the cancer cells. The Ki-67 however 
justifies the rate and extent of cell division within the BPH 
and PCa tissues; the BPH showed high ECAD expression, 
indicating that the epithelium is intact, although rate of cell 
proliferation and division is high as the BPH epithelium 
exhibits significant Ki-67 expression (Fig. 2, BPH/S29). 
Despite indication that cell proliferation is characteristic of 
both BPH and PCa, the patterns of such proliferation differs 
to a large extent. Also, the epithelial integrity is maintained 
in BPH as against PCa where ECAD expression is reduced 
and cells are allowed to migrate from the epithelium to 
invade the surrounding glandular tissue (Fig. 3 BPH and 
PCa).  
 Scientific studies have showed that low level ECAD 
expression is an indication of onset malignancy in tumors. 
Although digital rectal examination captured both PCa and 
BPH as tumors, the neoplasm observed in PCa is not 
characteristic of BPH tissue and ECAD expression which is 
relatively high in the proliferating epithelium (Fig. 1). Both 
PCa and BPH can be described as a function of a 
dysregulated cell cycle control mechanism comprising of 
series of switch systems governed by cycling and cyclin 
dependent kinases (Cdks), which in turn controls specific 
protein and gene expression patterns. Like all other cell cycle 
control molecules, the kinases are important factors in 
 
Fig. (1). General morphology of prostate biopsies on PCa and BPH Diagnosed patients. Paraffin wax embedded sections were stained in 
Hematoxylin and Eosin following the methods of Zhang et al. (2012). It is important to note the tissue infiltration sites in PCa Biopsies (S09, 
S20 and S30) and increased cell proliferation in BPH epithelium (Magnification X400). 
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controlling the expression of ECAD and Ki-67. Certain 
cancers are not directly linked with the proteins but will 
rather affect the kinase system that controls the transcription 
level of the genes encoding for such proteins [14]. Other 
forms of cancer can result from DNA damage; this was 
mapped alongside with cell proliferation using Ki-67 to 
immunohisto-chmeically differentiate these cells in PCa and 
BPH biopsies. The intensity of expression of these 
parameters was then compared between the groups to 
determine the extent of cell proliferation and malignancy 
between different PCa specimens and also between PCa and 
BPH specimens. Total Ki-67 expression levels corresponded 
with the extent of invasion of the tumor cells, being higher in 
the more invasive tumor cells that stained strongly with the 
anti-Ki-67 MAb and DAB (the polymer). ECAD expression 
levels also showed positive correlation with the extent of 
invasion. Although, certain cells that were found as isolated 
tumor masses were negative in immunohistochemistry for 
ECAD and only slightly positive for Ki-67 showing that, 
though the cells were malignant, the tumor cells were less 
radical and invasive when compared with those with high 
levels of Ki-67 (Fig. 2 PCa/S09). The study also showed that 
high Ki-67 reactivity correlates with the histological grade of 
tumor observed in routine Hematoxylin and Eosin (Fig. 1). 
 
Fig. (2). Immunohistochemical demonstration of Ki-67 in the epithelium of BPH biopsies using anti Ki-67 MAb. It is important to note that 
immunopositivity in the tissues is restricted to the base of the epithelium and restricted to specific tissue sites (S29, S39 and S40). Over 
expression of Ki-67 was observed in the PCa biopsies, particularly in cell clumps located at random within tissues. High expression of Ki-67 
in S09 and S30 shows rapid cell proliferation within the tumorgenic cell aggregations invading the glandular tissue of the prostate. 
(Magnification X400). 
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 Most of the human cancers originate from the epithelium 
because they consist of cells that are characterized by a very 
high rate of proliferation [15]. The regular epithelium is 
organized by a series of intercellular junctional complexes 
usually the adherent junction and desmosomes that connects 
the cells to one another and to the cellular cytoskeleton of 
actin filaments and microtubules, such that the epithelium is 
organized into a framework of single cell layer barrier [16]. 
This cytoskeletal adhesion, however, is necessary to stabilize 
the epithelial structure. The cadherin molecules are 
important in maintaining the adherent junctions via calcium 
mediated cell-cell interaction [17]. One of the most 
predominant cadherin molecules is E-Cadherin, a 
transmembrane protein that creates ECAD interaction 
between 2 cells (calcium dependent) [1, 11]. It is logical to 
summarize that CK7 can mark for PCa of glandular origin, 
thus important in characterizing neoplasm tissue mass at the 
interphase of epithelium and glandular tissue (Fig. 2 PCa). 
Finally, ECAD part positivity in glandular neoplastic tissue 
suggests tissue invasion by the cancer cells and the intact 
nature of others, while ECAD positivity in the epithelium of 
BPH tissues supports cell proliferation with intact epithelial 
interaction rather than neoplasm and cell detachment (Fig. 3 
PCa and Fig. 3 BPH). 
 
Fig. (3). ECAD positivity was restricted to the epithelium close to the origin of the PCa. Certain cells in the neoplasm show ECAD negativity 
which depicts the loss of desmosomes or hemi-desmosomes. Such a tumor is most likely going to become malignant as it has detached from 
the tumor mass within the tissue. BPH: ECAD positivity was observed in the epithelial tissue of BPH biopsies, showing proliferation but no 
evidence of detachment. This is important as a control factor; although certain cells in BPH biopsies were found to be CK7 positive. It is 
possible that inflamed cells resulting from stress factors in BPH contributes to such immunopositivity rather than PCa. (Magnification 
X400). 
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 Different antibodies can directly label nuclear antigens 
expressed at the various stages of the cell cycle. The Ki-67 is 
a nuclear non histone protein that is related to the S- and M-
Phases and the associated G phases (G1 and G2) of the cell 
cycle; the protein has a molecular weight of 345KDa. The 
use of this antibody as a proliferation marker is 
advantageous over flow cytometry as it combines both 
immunolabelling and immune-phenotyping, the turn over 
time is shorter than flow cytometry and it can assist 
clinicians in managing a lot of conditions. A major limitation 
of this technique in labeling ECAD and Ki-67 is the 
requirement for antigen retrieval as certain antigens might 
have been destroyed during fixation and tissue processing. 
This study however provides deep insight into the labelling 
of Ki-67 and ECAD using immunohistochemistry, 
specifically the antigen retrieval in paraffin wax embedded 
sections to determine cell proliferation and epithelial 
integrity that can give a reasonable insight into the 
aggressive nature of tumor cells and the extent of metastasis 
observed in such cells. 
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